Utomo, Rohmad Yudi and Meiyanto, Edy and Susidarti, Ratna Asmah (2025) GSH-conjugation Reduces PGV-1 Cytotoxicity and Its Ability in Downregulating N-Myc, β-catenin, and p62 Protein in Huh-6 Cells. Indonesian Biomedical Journal, 17 (4). 353 - 362. ISSN 20853297
3634-10033-1-PB.pdf - Published Version
Restricted to Registered users only
Download (3MB) | Request a copy
Abstract
BACKGROUND: Pentagamuvone-1 (PGV-1), a synthetic curcumin analogue, exhibits potent anticancer activity against Hepatocellular Carcinoma (HCC) by disrupting cell cycle regulation and downregulating key oncogenes such as N-Myc. Numerous studies have examined the role of glutathione (GSH) conjugation in modulating the anticancer properties of curcumin and its analogues. In contrast, the impact of PGV-1 metabolism, particularly GSH conjugation, and its implications for anticancer efficacy have not yet been elucidated. This study was performed to prepare GSH-conjugated PGV-1 (PGV-1-(GSH)<sub>2</sub>) as the model of PGV-1 metabolite and evaluate its potential distinct cytotoxicity on Huh-6 cells. METHODS: PGV-1 was synthesized via an acid-catalyzed reaction between 4-hydroxy-3,5-dimethylbenzaldehyde and cyclopentanone while PGV-1-(GSH)<sub>2</sub> was obtained through reflux at 70<sup>o</sup>C for 2 hours. The cytotoxic effects of PGV-1 and PGV-1-(GSH)<sub>2</sub> on Huh-6 and JHH4, two HCC cells, were assessed using a cell counting kit-8 (CCK-8) assay, while immunoblotting was performed to evaluate their impact on N-Myc and its downstream protein such as β-catenin, and p62. RESULTS: PGV-1-(GSH)<sub>2</sub> was prepared through GSH conjugation of PGV-1 in orange color solution, as confirmed by Electrospray Ionization Mass Spectrometry (ESI-MS), Fourier Transform Infrared Spectroscopy (FT-IR), and Nuclear Magnetic Resonance (NMR) analysis. Cytotoxicity assays revealed that PGV-1-(GSH)<sub>2</sub> exhibited less potent anticancer activity against HCC cells than PGV-1. GSH conjugation also decreased the ability of PGV-1 in downregulating the N-Myc, β-catenin, and p62 protein level. CONCLUSION: The prepared PGV-1-(GSH)<sub>2</sub> reduces the cytotoxicity of PGV-1 and its ability on downregulating N-Myc, β-catenin, and p62 in Huh-6 cells. These findings highlight the need for further exploration about the study of PGV-1 metabolism which could affect the anticancer efficacy against HCC. Copyright © 2025 The Prodia Education and Research Institute. This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC-BY-NC) License.
| Item Type: | Article |
|---|---|
| Additional Information: | Cited by: 0; All Open Access; Gold Open Access; Green Open Access |
| Subjects: | R Medicine > RM Therapeutics. Pharmacology R Medicine > RS Pharmacy and materia medica |
| Divisions: | Faculty of Pharmacy |
| Depositing User: | Muh Aly Mubarok |
| Date Deposited: | 28 Oct 2026 01:47 |
| Last Modified: | 28 Oct 2026 01:47 |
| URI: | https://ir.lib.ugm.ac.id/id/eprint/30252 |
